A United Kingdom supplier, with 3 awarded contracts, totalling £63.0m, most recently 8 months ago.
This procurement opportunity involves the acquisition of antiviral medications as part of the National Treatment and Monitoring Program for individuals with HIV/AIDS and post-exposure treatment. The procurement is divided into 20 lots. Interested suppliers must request clarifications or additional i
This procurement procedure involves the acquisition of various medicines and antineoplastics, divided into 301 lots as specified in the public procurement documentation. Contracts will be awarded quarterly, and the quantities listed are estimates. The contracting authority is not obligated to purcha
This procurement opportunity is for the acquisition of antiviral medications specifically for systemic use in the treatment of HIV. Suppliers are invited to refer to Section II.2, the list of lots in this announcement, and the specifications outlined in Annex 1 for quantities and values. Suppliers c
This contract involves the supply of Human Immunoglobulin at a concentration of 50 g/l in a 100 ml infusion bottle. Suppliers are required to adhere to the specifications outlined in the tender documents. The contracting authority will respond clearly and completely to all requests for clarification
The procurement involves acquiring a variety of medicines, divided into 160 lots, as outlined in the public procurement procedure. Suppliers are invited to submit their offers for these lots, adhering to the specifications detailed in the Terms of Reference. Suppliers have 18 days to request clarifi
The contracting authority is seeking suppliers for a range of medicines, specifically antineoplastic drugs. Suppliers are encouraged to submit their bids for this opportunity. The contracting authority will respond clearly and completely to all requests for clarification or additional information by
